Expand AKRO Menu

AKRO Stock Summary and Trading Ideas (Akero Therapeutics | NASDAQ:AKRO)

Charts for Today's Stock Price and Implied Volatility in Akero Therapeutics

Stock Price & Volume | Full Chart

30-Day Implied Volatility | IV30 Full Chart

Trade Ideas for Best Option Strategies for AKRO by Theoretical Edge and Win Rates


Trading Statistics

Key Ratios

Akero Therapeutics (AKRO) Frequently Asked Questions

What does Akero Therapeutics do?

Akero Therapeutics Inc is a clinical-stage biotechnology company focused on developing and commercializing transformative treatments for serious metabolic diseases with high unmet medical needs. Its focus is nonalcoholic steatohepatitis, or NASH, a disease without any approved therapies. The company's product candidate efruxifermin is an FGF21 analog with properties that has the potential to address the core processes underlying NASH pathogenesis.

What symbol and exchange does Akero Therapeutics stock trade?

Akero Therapeutics trades on the NASDAQ stock market under the symbol AKRO.

What is Akero Therapeutics stock price doing today?

As of December 6, 2023, AKRO stock price climbed to $19.06 with 1,059,796 million shares trading.

What is Akero Therapeutics's Beta?

AKRO has a beta of 1.96, meaning it tends to be more sensitive to market movements. AKRO has a correlation of 0.04 to the broad based SPY ETF.

How much is Akero Therapeutics worth?

AKRO has a market cap of $1.06 billion. This is considered a Small Cap stock.

What is the highest and lowest price Akero Therapeutics traded in the last 3 year period?

In the last 3 years, AKRO stock traded as high as $58.38 and as low as $7.52.

What are the top ETFs holding Akero Therapeutics?

The top ETF exchange traded funds that AKRO belongs to (by Net Assets): XBI, IWM, VTI, VXF, IWO.

Is Akero Therapeutics (AKRO) a good investment?

AKRO has underperformed the market in the last year with a return of -56.7%, while the SPY ETF gained +15.4%. In the last 3 month period, AKRO fell short of the market, returning -61.9%, while SPY returned +1.6%. However, in the most recent 2 weeks AKRO has outperformed the stock market by returning +18.6%, while SPY returned +0.3%.

What is the support and resistance for Akero Therapeutics (AKRO) stock price?

AKRO support price is $17.47 and resistance is $19.17 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that AKRO stock will trade within this expected range on the day.